The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer - EP3254695

The patent EP3254695 was granted to Astellas Pharma on Sep 9, 2020. The application was originally filed on May 21, 2013 under application number EP17171169A. The patent is currently recorded with a legal status of "Revoked".

EP3254695

ASTELLAS PHARMA
Application Number
EP17171169A
Filing Date
May 21, 2013
Status
Revoked
Feb 18, 2025
Publication Date
Sep 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR H ULRICH DORRIESJun 9, 2021DORRIESADMISSIBLE
DR H ULRICH DORRIESJun 9, 2021DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0338841
DESCRIPTIONUS2003118592
DESCRIPTIONUS2003133939
DESCRIPTIONWO0243478
DESCRIPTIONWO2004035607
DESCRIPTIONWO8704462
DESCRIPTIONWO8901036
EXAMINATIONWO2008145338
OPPOSITIONWO2008145338
SEARCHUS2012020989
SEARCHWO2010009794
SEARCHWO2011090005

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents